The National Cancer Institute is offering this grant opportunity (NOFO) to stimulate innovative research and development in the field of ultra-rare pediatric and adult cancers. This grant is specifically designed to encourage new approaches for supporting therapeutic development in these challenging conditions. It also includes molecularly-defined subsets of more common cancers, recognizing that even widespread cancer types can have unique, rare molecular characteristics requiring specialized therapeutic strategies. The initiative aims to accelerate the discovery and advancement of treatments for these often overlooked conditions, ultimately improving outcomes for patients with extremely rare oncological diagnoses. Clinical trial components are optional, allowing flexibility in research design.
Opportunity ID: 352144
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-FD-24-038 |
| Funding Opportunity Title: | Novel Approaches to Support Therapeutic Development in Ultra-Rare Cancers (U01) Clinical Trial Optional |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Agriculture Consumer Protection Food and Nutrition |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.103 — Food and Drug Administration Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 31, 2024 |
| Last Updated Date: | Jan 31, 2024 |
| Original Closing Date for Applications: | Apr 05, 2024 |
| Current Closing Date for Applications: | Apr 05, 2024 |
| Archive Date: | May 05, 2024 |
| Estimated Total Program Funding: | $500,000 |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Independent school districts Native American tribal governments (Federally recognized) Small businesses State governments Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments County governments For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities City or township governments Private institutions of higher education |
| Additional Information on Eligibility: | Foreign Organizations Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement are allowed. |
Additional Information
| Agency Name: | Food and Drug Administration |
| Description: |
The purpose of this NOFO is to encourage new approaches to support therapeutic development in ultra-rare pediatric and adult cancers, including molecularly-defined subsets of more common cancers. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Zahara Graves
Grantor Phone 240-402-0151 Email:zahara.graves@fda.hhs.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | Zahara Graves Grantor Phone 240-402-0151 Email: zahara.graves@fda.hhs.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.103 | RFA-FD-24-038 | FORM H | PKG00284670 | Feb 05, 2024 | Apr 05, 2024 | View |
Package 1
Mandatory forms
352144 RR_SF424_5_0-5.0.pdf
352144 PHS398_CoverPageSupplement_5_0-5.0.pdf
352144 RR_OtherProjectInfo_1_4-1.4.pdf
352144 PerformanceSite_4_0-4.0.pdf
352144 RR_KeyPersonExpanded_4_0-4.0.pdf
352144 RR_Budget_3_0-3.0.pdf
352144 PHS398_ResearchPlan_5_0-5.0.pdf
352144 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
352144 RR_SubawardBudget30_3_0-3.0.pdf
352144 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
